FDA NDC Directory · JSON-LD · Markdown
NDC 44567-840 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION
| Labeler / Manufacturer | WG Critical Care, LLC |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA211413 |
| Dosage form / route | INJECTION, POWDER, FOR SOLUTION · INTRAVENOUS |
| Active ingredients | CEFAZOLIN SODIUM (2 g/1) |
| Marketing started | 20230518 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).